The main market opportunities lie in enhancing supply chain resilience, reducing production costs and cycle times, and ...
Deerfield Management, Khosla Ventures, and Sofinnova Partners co-lead Series A fundraise for Excelsior Sciences to accelerate drug discovery and clinical development while supporting pharma reshoring.
Artificial intelligence chemistry outfit Excelsior Sciences is gaining ground on its quest to hasten the discovery and production of small molecules. The New York City-based company, which spun out of ...
This article and associated images are based on a poster originally authored by Adam Buckle, Julia Unsicker and Iain McWilliam and presented at ELRIG Drug Discovery 2025 in affiliation with Arrayjet ...
Key market opportunities for the global small molecule healthcare contract manufacturing sector include increased demand for cost-efficient production, rising outsourcing by pharmaceutical firms, ...
The goal of a small-molecule drug discovery campaign is the development of chemical entities that fulfil the criteria of the target product profile for progression into clinical trials. This objective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results